Back to search

University of Washington

Investigation of cellular and molecular targets in the brain of mice given intranasal GHK peptide to treat age-related cognitive decline

Abstract

dc:description.abstract

There are currently 1.2 billion people worldwide over the age of 60 and this number is projected to double by 2050. With the world population over 60 reaching 22% within the next 50 years, there is an increasing need to understand the mechanisms and processes of aging. An area of major interest is brain aging given that approximately 2 out of 3 Americans experience some level of cognitive impairment by age 70. Neuropathology associated with this cognitive impairment can lead to more severe neuropathology associated with Alzheimer’s disease and other dementias providing a need to develop interventions to treat and potentially prevent or reverse age related cognitive decline. One particular therapeutic of interest is a naturally occurring peptide called glycyl-L-histidyl-L-lysine (GHK) as recent studies suggest that GHK in its Cu bound form has the potential to age related cognitive decline. In order to further investigate the potential of GHK-Cu as a therapeutic for age related cognitive decline, mouse hippocampal tissue from 20-month-old C57BL/6 mice treated with 15mg/kg of intranasal GHK-Cu daily for 8 weeks were used for immunohistochemistry and RNA sequencing to discover cellular and molecular targets of this peptide. Results suggested that mice treated with intranasal GHK-Cu had lower expression of potentially harmful astrocytes. RNA sequencing results revealed that mice treated with GHK-Cu had upregulation or downregulation of various gene pathways in a way that supports healthy brain aging. Sex differences were also observed with certain pathways being affected differently in males and females. These findings provide rationale for further investigation of GHK-Cu as a therapeutic for age related cognitive decline in preclinical and clinical studies.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Rosenfeld, Manuela
Advisor dc:contributor.advisor
  • Ladiges, Warren

Subjects

dc:subject × 2

Rights

dc:rights
Statement dc:rights
  • none
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1773/53342

Chain of custody

source
Harvested from
University of Washington
Base URL
digital.lib.washington.edu/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Rosenfeld, Manuela. Investigation of cellular and molecular targets in the brain of mice given intranasal GHK peptide to treat age-related cognitive decline. 2025. https://hdl.handle.net/1773/53342